Heart disease still claims more lives each year than any other condition. Yet most heart risk assessments remain stuck in the past. We measure total cholesterol. LDL. HDL. Then we decide who’s “at risk.”
In the webinar Beyond Cholesterol: How CardioZoomer + Cardio Genetics Change the Game, Dr. Giovanni Campanile challenges that entire framework. His message is clear. Cholesterol alone does not tell the story. Not even close.
CardioZoomer was built to reveal what standard testing overlooks. And what it uncovers changes everything.
Why Traditional Cholesterol Testing Falls Short
Basic lipid panels were never designed to predict disease with precision. They offer averages. Snapshots. Surface-level clues.
Heart disease, however, is not a surface problem. It develops quietly. Years earlier than symptoms. At the level of inflammation, oxidative stress, and vascular injury. Many patients suffer heart attacks despite “normal” cholesterol numbers. That disconnect isn’t rare. It’s common.
Cholesterol is involved, yes. But it is only one player in a much larger system.
What CardioZoomer Actually Measures
CardioZoomer expands the lens. Instead of focusing on a few lipid values, it evaluates the biological processes that drive cardiovascular damage in real time.
It looks at:
- Metabolic health and insulin resistance
- Oxidative stress and redox imbalance
- Inflammatory activity linked to plaque formation
- Omega fatty acid status
- Endothelial dysfunction
- Ceramides and sterol balance
- Markers tied to clotting and cardiac stress
This isn’t redundancy. It’s context. Each marker answers a different question about risk.
The Endothelium Changes the Timeline
One of the most important insights from the transcript centers on the endothelium. A single-cell lining inside every artery. Thin. Fragile. Powerful.
When the endothelium functions well, arteries stay resilient. When it breaks down, everything else follows. Lipids slip into the vessel wall. Inflammation escalates. Plaque takes hold. CardioZoomer tracks biochemical signals that reflect endothelial stress long before imaging can detect disease. That shift moves prevention earlier. Much earlier.
Why Inflammation Often Matters More Than Cholesterol
Large clinical trials show something important. For example, lowering inflammation can reduce heart problems, even when cholesterol stays the same.
Inflammation weakens plaque and protective barriers. As a result, it speeds up rupture. That is why CardioZoomer looks at inflammatory drivers directly, rather than assuming cholesterol tells the full story. Heart disease isn’t just buildup. Instead, it’s biology in motion.
A More Honest Risk Conversation
CardioZoomer doesn’t simplify heart health. Instead, it clarifies the issue, helping clinicians understand why risk exists, not just whether it does. Moreover, it explains why two people with similar cholesterol levels can face radically different outcomes. And it opens the door to personalized prevention instead of generic thresholds. The hidden scoreboard has always been there. Now we finally know how to read it.
